Illumina Files Patent Infringement Suit Against BGI in Denmark

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed another patent infringement suit against one of BGI Group’s subsidiaries, BGI Europe A/S. Illumina filed suit in the Maritime & Commercial High Court of Denmark. “As we have previously stated, Illumina will continue to vigorously protect our patented technology and file patent suits... Read more

Thermo Scientific SureTect Real-Time PCR Pathogen Detection System provides an easy-to-use workflow for rapid, accurate pathogen detection

Thermo Scientific SureTect Real-Time PCR Pathogen Detection System provides an easy-to-use workflow for rapid, accurate pathogen detection Extended validation scope means more streamlined rapid pathogen testing for food-testing laboratories BASINGSTOKE, England, May 15, 2019 /PRNewswire/ — Thermo Scientific SureTect PCR Assays are now validated to run on the Applied Biosystems SimpliAmp Thermal Cycler and Applied Biosystems... Read more

New tissue clearing kits and reagents for faster, accurate 3D imaging

New tissue clearing kits and reagents for faster, accurate 3D imagingAbcam’s tissue clearing kits and reagents enable easy and rapid clearing for 3D imaging of tissues and cell culture models. Traditionally, 3D imaging of thick tissue sections and 3D cell culture models (organoids, microtissues, spheroids) has presented many technical challenges, including laborious and time-consuming tissue processing, layer-by-layer... Read more

IDT brings unmatched customization to NGS

May 9, 2019 Launch of Custom NGS Adapters and portfolio expansion delivers unprecedented flexibility and ease-of-use CORALVILLE, IA (May 9, 2019) – Demonstrating its advocacy for genomics research, Integrated DNA Technologies (IDT) announces a significant expansion to its NGS portfolio. The company is excited to launch a unique Custom NGS Adapters offering, becoming the only genomics provider to provide an... Read more

Agilent Announces Unique Portfolio to Advance Immunotherapy

Agilent Announces Unique Portfolio to Advance Immunotherapy Innovative solution provides cell-based tools for translational research and development SANTA CLARA, Calif., May 7, 2019 Agilent Technologies Inc. (NYSE: A) announces a unified portfolio of products for immunotherapy researchers. The innovative solution will showcase at Immunology 2019, the 103rd Annual Meeting of the American Association of Immunologists... Read more

New England Biolabs® launches myNEB™, a first of its kind voice-activated digital lab assistant for Alexa

The new cloud-based service enables quick access to scientific information — including key restriction enzyme details — for molecular biologists in the lab. Ipswich, MA (May 3rd, 2019) — Imagine you’re at the bench performing a restriction enzyme digest, and you need information about an enzyme and don’t want to have to take your gloves off. myNEB, an... Read more

New England Biolabs® Launches NEBNext® Enzymatic Methyl-seq (EM-seq™) for bisulfite-free methylation analysis

This new enzyme-based system allows scientists to accurately and sensitively assess DNA methylation without bisulfite treatment, for epigenetics research. IPSWICH, MA (April 29, 2019) — New England Biolabs (NEB®) today announced the launch of NEBNext® Enzymatic Methyl-seq (EM-seq™), an enzyme-based alternative to bisulfite sequencing for methylation analysis. Bisulfite treatment has long been the gold standard for... Read more

GrandOmics collaborates with Oxford Nanopore to deliver dbSV-100k, a project to sequence 100,000 affordable nanopore long-read human genomes

Thu 25th April 2019 Strategic collaboration between two organisations represents largest nanopore sequencing project to date, capitalising on recent developments bringing ultra-high yields with PromethION GrandOmics, a leading sequencing company in China, has announced a populational-scale project, dbSV100k, to understand the impact of structural variation on human disease. The project aims to sequence 20,000 human... Read more

Pacific Biosciences Launches New Sequel II System, Featuring ~8 Times the DNA Sequencing Data Output

New system is ideally suited for comprehensive variant detection, large genome de novo assembly, human structural variant characterization, whole transcriptome analysis, and moreMENLO PARK, Calif., April 24, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced the commercial launch of the... Read more